Stéphanie Durand-Panteix

Author

Also Known As

S Durand-Panteix, S. Durand-Panteix, Stéphanie Durand-Panteix, Stéphanie DURAND-PANTEIX, Stéphanie Durand-Panteix

Publications

172

Citations

H-Index

Concepts

All Affiliations

Stéphanie Durand-Panteix is an author at Université de Limoges specializing in medicine, immunology, and humoral immunity.

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	133
2	Immunology	4	4	133
3	Cell Biology	3	3	108
4	Pathology	3	3	97
5	Autoimmune Disease	1	1	36

Stéphanie Durand-Panteix

Publications

167

Citations

H-Index

Page 1

	Year	Citations
c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells Nathalie Faumont, Stéphanie Durand-Panteix, Martin Schlee, Journal of Virology Immune RegulationImmunologyPathologyCell ProliferationImmune System	2009	56
B7-H1, Which Represses EBV-Immortalized B Cell Killing by Autologous T and NK Cells, Is Oppositely Regulated by c-Myc and EBV Latency III Program at Both mRNA and Secretory Lysosome Levels Stéphanie Durand-Panteix, Mona Farhat, Ibtissam Youlyouz‐Marfak, The Journal of Immunology Adaptive Immune SystemEbv-immortalized B CellsImmunologyImmune RegulationCell Death	2012	36
<sup>212</sup>Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study Isabelle Quelven, Jacques Monteil, Magali Sage, Journal of Nuclear Medicine	2019	34
Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma Stéphanie Durand-Panteix, Jacques Monteil, Magali Sage, British Journal of Cancer Lymphoid NeoplasiaMedicineMalignant Blood DisorderImmunologyNon-hodgkin Lymphoma	2021	25
RelA and RelB cross-talk and function in Epstein–Barr virus transformed B cells A. Chanut, Fanny Duguet, Abdelghafour Marfak, Leukemia Relb Cross-talkHumoral ResponseImmunologyB CellsPathology	2013	16

Page 1